91 related articles for article (PubMed ID: 125655)
21. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of solubilized 5-HT1 serotonin binding sites from bovine brain.
Allgren RL; Kyncl MM; Ciaranello RD
Brain Res; 1985 Nov; 348(1):77-85. PubMed ID: 4063829
[TBL] [Abstract][Full Text] [Related]
23. Affinity chromatography for subfractionation of 5-hydroxytryptamine-, LSD-binding proteins from cerebral and nerve-ending membranes.
Mehl E; Weber L
Adv Biochem Psychopharmacol; 1974; 11(0):105-8. PubMed ID: 4845693
[No Abstract] [Full Text] [Related]
24. Specific in vivo binding of d-LSD in rat brain.
Kräuchi K; Feer H; Lichtsteiner M; Wirz-Justice A
Experientia; 1978 Jun; 34(6):761-2. PubMed ID: 658293
[TBL] [Abstract][Full Text] [Related]
25. Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.
Grahame-Smith DG; Geaney DP; Schachter M; Elliott JM
Experientia; 1988 Feb; 44(2):142-5. PubMed ID: 2894321
[TBL] [Abstract][Full Text] [Related]
26. On the antagonism of ergot alkaloids and dopamine by phenothiazines.
Stone TW
Experientia; 1974 Jul; 30(7):827-9. PubMed ID: 4847689
[No Abstract] [Full Text] [Related]
27. The subcellular distribution of lysergic acid diethylamide in the rat brain.
Faragalla FF
Experientia; 1972 Dec; 28(12):1426-7. PubMed ID: 4654194
[No Abstract] [Full Text] [Related]
28. Photoreactivity of lysergic acid diethylamide and its possible utility as a photoaffinity labeling reagent.
Walker EB; McNall SJ; Mansour TE
Biochem Pharmacol; 1983 Apr; 32(7):1251-7. PubMed ID: 6847715
[TBL] [Abstract][Full Text] [Related]
29. Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs.
Lovell RA; Freedman DX
Mol Pharmacol; 1976 Jul; 12(4):620-30. PubMed ID: 8700
[No Abstract] [Full Text] [Related]
30. Studies on enzymatic dealkylation of D-lysergic acid diethylamide (LSD).
Niwaguchi T; Inoue T; Nakahara Y
Biochem Pharmacol; 1974 Mar; 23(6):1073-8. PubMed ID: 4151050
[No Abstract] [Full Text] [Related]
31. Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.
Whitaker PM; Seeman P
Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5783-7. PubMed ID: 32537
[TBL] [Abstract][Full Text] [Related]
32. Interactions of neomycin and calcium in synaptosomal membranes and polyphosphoinostide monolayers.
Lodhi S; Weiner ND; Schacht J
Biochim Biophys Acta; 1976 Apr; 426(4):781-5. PubMed ID: 1259992
[TBL] [Abstract][Full Text] [Related]
33. Lysergic acid diethylamide (LSD-25) antagonists: chlorpromazine.
ABRAMSON HA; ROLO A; STACHE J
J Neuropsychiatr; 1960; 1():307-10. PubMed ID: 13791577
[No Abstract] [Full Text] [Related]
34. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
Enna SJ; Bennett JP; Burt DR; Creese I; Snyder SH
Nature; 1976 Sep; 263(5575):338-41. PubMed ID: 8733
[No Abstract] [Full Text] [Related]
35. [Effect of LSD on synaptosomal Mg++ (Na+, K+)-ATPase].
Uebelhack R; Franke L; Seidel K
Acta Biol Med Ger; 1978; 37(7):1135-7. PubMed ID: 218411
[No Abstract] [Full Text] [Related]
36. The fate of lysergic acid DI[14C]ethylamide ([14C]LSD) in the rat, guinea pig and rhesus monkey and of [14C]iso-LSD in rat.
Siddik ZH; Barnes RD; Dring LG; Smith RL; Williams RT
Biochem Pharmacol; 1979 Oct; 28(20):3093-101. PubMed ID: 117811
[No Abstract] [Full Text] [Related]
37. Selective inhibition of [3H]lysergic acid diethylamide binding to mouse brain membranes by ethanol.
Hirsch JD
J Pharm Pharmacol; 1981 Jul; 33(7):475-7. PubMed ID: 6115041
[No Abstract] [Full Text] [Related]
38. The nature of the binding between LSD and a 5-HT receptor: a possible explanation for hallucinogenic activity.
Berridge MJ; Prince WT
Br J Pharmacol; 1974 Jun; 51(2):269-78. PubMed ID: 4375525
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of [3H] diazepam binding to rat brain cortical synaptosomal membranes by adenosine uptake blockers.
Wu PH; Phillis JW; Bender AS
Eur J Pharmacol; 1980 Aug; 65(4):459-60. PubMed ID: 7408953
[No Abstract] [Full Text] [Related]
40. N1-methyl-2-[125I]LSD ([125I]MIL), a preferred ligand for serotonin 5-HT2 receptors.
Hoffman BJ; Karpa MD; Lever JR; Hartig PR
Eur J Pharmacol; 1985 Mar; 110(1):147-8. PubMed ID: 4007051
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
